The global veterinary CRO market was valued at USD 770.8 million in 2024 and is projected to surpass USD 1.6 billion by the end of 2035. The industry is expected to grow at a CAGR of 7.1% from 2025 to 2035, driven by increasing demand for animal health innovations, rising pet ownership, and expanding investments in veterinary drug development and clinical research services.

Get sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86567

Market Overview

Veterinary Contract Research Organizations (CROs) play a significant role in research, development, and approval of veterinary products such as pharmaceuticals, vaccines, and medical devices. Veterinary CROs are experts in providing a wide range of services that support the research and development processes involved in bringing new animal health products to market. They include preclinical research, clinical trial management, regulatory affairs, and post-market surveillance.

Preclinical trials imply laboratory research and toxicology testing to understand how a product behaves with biological systems. After preclinical trials are conducted, veterinary CROs oversee clinical trials, which, in various phases, accrue data on the performance of the product among the population of targeted animals.

Such experiments are planned meticulously to meet the regulatory requirements of organizations like the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA).

In addition to research and trial handling, veterinary CROs also extend regulatory affairs services to simplify the approval process on behalf of clients. In addition to these essential services, veterinary CROs may further specialize in data management, statistical analysis, and consultancy, with actionable insights available to clients for strategic decision-making.

Analysts’ Viewpoint on the Veterinary CRO Market

Ongoing trend of pet ownership, growing awareness of animal health, technological innovations in veterinary medicine and diagnostics, and increased investment in research and development activities for animal drugs are factors anticipated to boost the veterinary CRO market.

Several pharmaceutical and biotechnology companies are increasingly outsourcing research to CROs to minimize costs and enhance efficiency, thereby further driving market growth. Additionally, heightened focus on zoonotic diseases and their impact on public health encourages more veterinary research initiatives.

According to the latest veterinary CRO market trends, the major companies are taking proactive initiatives to enhance research capabilities and develop innovative solutions, thereby reflecting a shift toward more specialized veterinary services.

Analysis of Key Players in the Veterinary CRO Market

The landscape is characterized by significant consolidation, with large-scale human CROs acquiring boutique veterinary specialists to offer “end-to-end” life science services.

Leading companies operating in the veterinary CRO market include:

• Charles River Laboratories
• IDEXX Laboratories, Inc.
• BioAgile Therapeutics Private Limited
• Royal GD
• KLIFOVET GmbH
• Argenta Holdco Limited
• Cebiphar
• Clinvet
• STATKING Clinical Services
• OCRvet
• LÖHLEIN & WOLF VET RESEARCH
• VETSPIN SRL
• Inotiv
• Knoell
• Cloudbyz

Strategic moves like Argenta’s 2025 acquisition of Ondax Scientific and its subsequent 2026 realignment into regional divisions highlight the industry’s focus on localized regulatory expertise.

Recent Developments in the Veterinary CRO Market

• In January 2025, Argenta announced a strategic realignment of its CRO platform. Argenta’s CRO platform offers a comprehensive set of capabilities, inclusive of regulatory, pre-clinical, and clinical CRO services. The realignment of the CRO business is poised to strengthen the company’s customer value proposition by improving its capabilities to provide an end-to-end R&D and product development journey within the animal health industry.
• In October 2024, Clinglobal announced that it had completed the acquisition of OCRvet, a European CRO specializing in translational and animal health field trials. The acquisition has strengthened the company’s presence across Europe, with teams in France, Italy, and Poland.

Discuss Implications for Your Industry Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86567

Key Developments in the Veterinary CRO Market

• AI-Enabled Lead Optimization: Using AI to predict the efficacy of animal drugs before they enter the “wet-lab” phase.
• Decentralized Clinical Trials (DCTs): Leveraging mobile apps and home-based veterinary visits to improve recruitment for rare pet diseases.
• Focus on Longevity & Chronic Care: Significant increase in trials for geriatric pet conditions, such as osteoarthritis and cognitive dysfunction.
• Precision Livestock Farming (PLF): Integration of CRO services with “Smart Farm” tech to track drug metabolism in real-time.

Challenges & Opportunities

Challenges:

• Recruitment Barriers: Difficulty enrolling sufficient animal participants for specific disease studies.
• Regulatory Fragmentation: Varying approval standards across the US, EU, and emerging markets.
• Shortage of Specialists: Global deficit of veterinary pathologists and board-certified researchers.

Opportunities:

• Biologics & mAbs: High-margin potential in developing monoclonal antibodies for pet allergies and cancer.
• Start-up Surge: Rising VC funding for veterinary biotechs lacking in-house R&D infrastructure.
• Zoonotic Research: Increased public funding for “One Health” initiatives and pandemic prevention.

Market Segmentation

➤ By Service Type

• Clinical Trial Services (Largest segment, ~33% share)
• Toxicology Services
• Market Authorization & Regulatory Support (Fastest growth)
• Discovery & Preclinical Services

➤ By Animal Type

• Companion Animals (Dogs, Cats, Equine) — Leading in Revenue
• Livestock Animals (Cattle, Swine, Poultry) — Leading in Volume

➤ By Indication

• Oncology (Highest CAGR)
• Infectious Diseases
• Dermatology
• Pain Management

To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=86567&ltype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com